Showing results (631-640 of 835) with videos related to
Sort By:
Pageof 84
Psychopharmacology Bulletin|January 1, 1990
Is maintenance antiparkinsonian treatment necessary?J E Comaty, P G Janicak, J Rajaratnam, et al.Kidney International|April 1, 1980
Feedback activation in rat nephrons by sera from patients with acute renal failureP F Wunderlich, F P Brunner, J M Davis, et al.Journal of Environmental Pathology and Toxicology|September 1, 1980
Relationships between selenium and other parameters in drinking water and blood of subjects from high and low cardiovascular disease rate areas of GeorgiaJ W Andrews, C G Hames, J C Metts, et al.The Journal of General Physiology|August 1, 1978
Lithium transport pathways in human red blood cellsG N Pandey, B Sarkadi, M Haas, et al.Inhalation Toxicology|September 16, 2000
Pathogenicity of a special-purpose glass microfiber (E glass) relative to another glass microfiber and amosite asbestosR T Cullen, A Searl, D Buchanan, et al.Critical Reviews in Neurobiology|December 8, 2004
A GABAergic cortical deficit dominates schizophrenia pathophysiologyE Costa, J M Davis, E Dong, et al.Carcinogenesis|May 1, 1985
Inhalation studies on the effects of tremolite and brucite dust in ratsJ M Davis, J Addison, R E Bolton, et al.Proceedings of the National Academy of Sciences of the United States of America|April 18, 1998
Increase in the cerebrospinal fluid content of neurosteroids in patients with unipolar major depression who are receiving fluoxetine or fluvoxamineV Uzunova, Y Sheline, J M Davis, et al.Pediatric Pulmonology|March 24, 1999
Improved pulmonary distribution of recombinant human Cu/Zn superoxide dismutase, using a modified ultrasonic nebulizerE G Langenback, J M Davis, C Robbins, et al.Drugs|May 1, 1994
Depot antipsychotic drugs. Place in therapyJ M Davis, L Matalon, M D Watanabe, et al.Pageof 84